Q3 Shows Ongoing Venture Fundraising Challenges In Tough Financial Market

Even Mega-Round Raisers Reflect Rough Going

 
• By Mandy Jackson

VC data from Evaluate show quarter-over-quarter drops in the number of biopharma companies raising private cash and in the amount of money raised as investors ride out public market troubles.

Venture capital dial on a blue background
The number of VC deals dipped significantly from Q2 to Q3 • Source: Shutterstock

More from Financing

More from Business